Abstract
Purpose of ReviewWe discuss the current state of genomic testing for cancer in the UK, how this has been impacted by whole genome sequencing (WGS) and the 100,000 Genomes Project, along with approaches to reviewing whole genome analyses.Recent FindingsThe 100,000 Genomes Project has led to the development of new pathways for tissue handling and processing, variant interpretation and clinical reporting of cancer genomic testing. To our knowledge, this is the first paper discussing the recommended review process for WGS reports by the Genomics Tumour Advisory Board.SummaryThrough wider use of WGS and next-generation sequencing technologies, the new NHS Genomic Medicine Service aims to expand precision oncology research and personalised cancer care. As research in cancer genomics progresses, the standards and guidelines for interpretation of WGS reports will continue to evolve.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
